Allogene Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Allogene Therapeutics, Inc. has filed 570 SEC EDGAR filings since 19 Apr 2018

SEC filing history

Showing 151-175 of 570 matching filings.

Per page
25
Current page
7
144 File 001-38693

144 filing

Filing date
21 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jun 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
18 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
11 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jun 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jun 2024
Reporting date
30 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38693

144 filing

Filing date
29 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 May 2024
Reporting date
16 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 May 2024
Reporting date
16 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 May 2024
Reporting date
16 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277951

424B5

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-277951

EFFECT filing

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .